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Abstract
Here, we aimed to investigate the potential role of DUSP6, a dual specificity phosphatase,
that specifically inactivates extracellular signal-regulated kinase (ERK), for the regulation
of body weight and glucose homeostasis. We further assessed whether metabolic chal-
lenges affect Dusp6 expression in selected brain areas or white adipose tissue. Hypotha-
lamic Dusp6 mRNA levels remained unchanged in chow-fed lean vs. high fat diet (HFD) fed
obese C57Bl/6J mice, and in C57Bl/6J mice undergoing prolonged fasting or refeeding with
fat free diet (FFD) or HFD. Similarly, Dusp6 expression levels were unchanged in selected
brain regions of Lepob mice treated with 1 mg/kg of leptin for 6 days, compared to pair-fed
or saline-treated Lepob controls. Dusp6 expression levels remained unaltered in vitro in pri-
mary adipocytes undergoing differentiation, but were increased in eWAT of HFD-fed obese
C57Bl/6J mice, compared to chow-fed lean controls. Global chow-fed DUSP6 KO mice dis-
played reduced body weight and lean mass and slightly increased fat mass at a young age,
which is indicative for early-age weight retardation. Subsequent exposure to HFD led to a
significant increase in lean mass and body weight in DUSP6 deficient mice, compared to
WT controls. Nevertheless, after 26 weeks of high-fat diet exposure, we observed compara-
ble body weight, fat and lean mass in DUSP6 WT and KO mice, suggesting overall normal
susceptibility to develop obesity. In line with the increased weight gain to compensate for
early-age weight retardation, HFD-fed DUSP6 KO displayed increased expression levels of
anabolic genes involved in lipid and cholesterol metabolism in the epididymal white adipose
tissue (eWAT), compared to WT controls. Glucose tolerance was perturbed in both chow-
fed lean or HFD-fed obese DUSP6 KO, compared to their respective WT controls. Overall,
our data indicate that DUSP6 deficiency has limited impact on the regulation of energy
metabolism, but impairs systemic glucose tolerance. Our data are in conflict to earlier
reports that propose protection from diet-induced obesity and glucose intolerance in DUSP6
deficient mice. Reasons for the discrepancies remain elusive, but may entail differential
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Müller TD, Tschöp MH, Stemmer K (2017) Dual
specificity phosphatase 6 deficiency is associated
with impaired systemic glucose tolerance and
reversible weight retardation in mice. PLoS ONE 12
(9): e0183488. https://doi.org/10.1371/journal.
pone.0183488
Editor: Ruben Nogueiras, Universidade de Santiago
de Compostela, SPAIN
Received: February 13, 2017
Accepted: August 3, 2017
Published: September 5, 2017
Copyright: © 2017 Pfuhlmann et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information
files.
Funding: The work was funded in part by the
Alexander von Humboldt Foundation (MHT), by the
Helmholtz Alliance ICEMED-Imaging and Curing
Environmental Metabolic Diseases (SCS, MHT), by
the Helmholtz-Israel-Cooperation in Personalized
Medicine (PTP), by the iMed Helmholtz Initiative for
Personalized Medicine (MHT), and through the
genetic backgrounds, environmental factors such as the type and source of HFD, or alter-
ations in the gut microbiome between facilities.
Introduction
In the late 20th century and new millennium, obesity has evolved from an isolated problem of
the rich and wealthy into a widespread global epidemic that spans all social classes. Under-
standing the underlying molecular mechanisms by which an organism becomes obese is a pre-
requisite for successful weight loss therapies. Obesity is characterized by an increase in adipose
tissue mass that includes increased fat cell size and fat cell number. The latter is characterized
by differentiation of fibroblast-like pre-adipocytes into mature adipocytes, and governed via
tightly controlled activation and inactivation of mitogen activated protein kinases (MAPKs).
These highly conserved serine/threonine kinases control the interplay between cell differentia-
tion, cell proliferation and cell death in multiple cell types [1].
Extracellular signal-regulated kinase (ERK) stands out as important positive [2,3][4,5] and
negative [6] regulator of the adipocyte differentiation process. Mice with global (germline)
ablation of ERK1 were shown to have decreased adiposity when fed high-fat diet (HFD),
which was attributed to impaired adipogenesis as well as increased thermogenesis [4]. The
plurality of ERK action towards multiple physiological processes, including adipocyte differenti-
ation, demands tight control of spatial and temporal ERK activity in relation to the physiological
state of the cell. Canonical RAF/MEK/ERK signaling, is activated by intracellular mitogenic and
stress stimuli as well as extracellular hormones such as leptin or ghrelin [7]. Fine-tuning of
canonical ERK signaling is achieved by scaffolding proteins such as kinase suppressor of RAS 1
(KSR1) [8,9] or KSR2 [10], which support the interaction of ERK with RAF/MEK or the phos-
phatase calcineurin, respectively, to localize active ERK to specific membrane microdomains
and substrates [11]. The duration and intensity of ERK activation is further modulated by dual-
specificity phosphatases (DUSPs), which inactivate ERK by dephosphorylating its serine/threo-
nine and tyrosine residues [12–14].
At current, 38 DUSP family members are known, and 11 use MAP kinases as substrate; of
those, only DUSP6 displays high selectivity for ERK1/2, the others are promiscuity towards
JNK, p38 or ERK [15]. Dusp6 is expressed in multiple tissues, with highest expression in the
brain [16], adipose tissue [17], heart and pancreas [15] and has been implicated in multiple
physiological processes ranging from brain development [18] and heart function [19] to
tumorigenesis [20–22].
Adult mice with DUSP6 deficiency displayed increased basal ERK activity states in multiple
organs such as heart, spleen, kidney and brain [19]. DUSP6 deficiency was further linked with
impaired adipocyte differentiation in vitro, and with decreased propensity for diet-induced
obesity and pernicious sequelae in mice chronically exposed to HFD [23]. In hepatocytes,
DUSP6 was shown to mediate forkhead box protein O1 (FOXO1) dephosphorylation and
nuclear translocation, which allowed an increased activation of gluconeogenic gene programs
and glucose output [17,24]. Accordingly, diminished hepatic Dusp6 expression was associated
with improved glucose homeostasis in both diet-induced obese (DIO) and leptin deficient
(Lepob) mice [25].
Our study aimed to assess a potential weight- and glucoregulatory role of DUSP6 in mice.
We moreover aimed to assess whether Dusp6 gene expression in adipose tissue and the hypo-
thalamus is directly affected by dietary and hormonal challenges. In contrast to previous
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studies, DUSP6 deficiency had only little impact on the regulation of energy metabolism or
lipid homeostasis. Moreover, rather than improving glucose tolerance, 16 weeks of HFD feed-
ing resulted in temporarily increased glucose excursions after a glucose bolus.
Methods
Mouse husbandry
Global DUSP6 wild type (WT) and knockout (KO) mice of mixed C57Bl/6J and 129 back-
ground were kindly provided by Prof. Jeffery Molkentin, Children’s Hospital Cincinnati [19].
Study cohort mice were bred true from WT and KO mice, and housed in positive individual
ventilation cages in dedicated animal housing rooms with a 12-h light, 12-h dark cycle (6am-
6pm) at 22˚C with free access to water and standard chow diet (Harlan Teklad LM-485) or
high fat diet (HFD; Research Diets D12331 Surwit Diet, 58% of calories from fat, New Bruns-
wick, NJ, USA). Initially, all mice were housed in groups of 2 to 4. By the end of the diet expo-
sure, 6 WT mice were housed 2 per cage, 2 WT mice were single housed, 6 KO mice were
housed 2 per cage and 3 KO mice 3 per cage due to fighting. Food intake was assessed in mice
exposed to HFD from week 3 to 5, with 3 WT mice being temporarily single housed to increase
statistical power. One cage of WT mice was excluded from the analysis due to spilling of the
food.
For the analysis of Dusp6 expression in lean vs. diet induced obese (DIO) mice, C57Bl/6J
mice (Jackson Laboratory, Bar Harbor, ME, USA) with an age of 8 to 10 weeks were either
maintained on chow or switched to HFD for 6 months. The impact of leptin on the central
nervous system (CNS) Dusp6 gene expression was assessed using adult chow-fed leptin-defi-
cient (Lepob) mice (71.12 ± 0.71 g) that once daily received subcutaneous injections of either
human recombinant leptin (1 mg/kg; R&D Systems) or vehicle (PBS). An additional group of
vehicle-treated Lepob mice was food restricted to receive daily only the amount of food eaten
by the leptin-treated mice (pair-fed to leptin). To assess the impact of fasting and re-feeding
on Dusp6 gene expression, male chow-fed C57BL/6J mice were subjected to 12, 24 or 36 h of
fasting as well as refeeding for 6 h with fat-free diet (FFD; 0% kcal from fat, D04112303
Research Diets) or HFD [26]. Mice were sacrificed by asphyxiation with CO2. All studies were
approved by and performed according to the guidelines of the Institutional Animal Care and
Use Committee of the University of Cincinnati, USA.
Glucose tolerance tests
Following 16 weeks of HFD feeding, DUSP6 WT and KO mice were fasted for 6 h, and subse-
quently subjected to an intraperitoneal injection of 2 g glucose per kg body weight (20% wt/vol
D-glucose in 0.9% wt/vol saline). Tail blood glucose levels (mg dl-1) were measured with a
handheld glucometer (TheraSense Freestyle) before (0 min) and at 15, 30, 60 and 120 min
after injection. Area under the curve values were calculated by using the statistical software
GraphPad Prism.
Primary adipocyte cell culture and differentiation
Primary murine pre-adipocytes were obtained from subcutaneous white adipose tissue of four
6- to 8-weeks old male C57BL/6J mice. Fat pads were kept separate during the isolation proce-
dure to obtain four biological replicates. Fat pads were dissected and minced in phosphate-
buffered saline (PBS) using spring scissors. Minced tissues were transferred to digestion buffer
containing collagenase IV (Life Technologies; 1 mg/ml), dispase II (Sigma Aldrich; 3 U/ml)
and CaCl2 (Sigma Aldrich; 0.01 mM) in PBS. Tissues were digested while shaking at 37˚C for
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50 min. Homogenates were filtered through a 100 μm strainer. The strainer was cleared with
growth media consisting of DMEM/F12 + glutaMAXTM (Thermo Fisher Scientific, #31331
028) with 10% FBS and 1% penicillin streptomycin, and cells were centrifuged at 500 x g for
10 min at room temperature. After removal of the supernatant the cells were re-suspended in
growth media and again filtered through a 70 μm strainer. Cells were re-suspended in growth
media, centrifuged at 500 x g for 10 min at room temperature, re-suspended in growth media,
seeded in cell culture plates, and maintained in an incubator with 10% CO2. The day after
extraction and then every other day the medium was changed. Before cells reached confluence,
living cells were counted and 0.15 x 105 cells were seeded per well in 12-well plates. One day
after cells reached confluence, differentiation was induced with growth media supplemented
with dexamethasone (Sigma Aldrich; 1 μM), IBMX (3-isobutyl-1-methylxanthine; Biomol;
0.5 μM), rosiglitazone (Santa Cruz; 1 μM) and insulin (Sigma Aldrich; 5 μg/ml). Two days
later and every other day until the end of the study, media were changed to growth media sup-
plemented with insulin (5 μg/ml). Plates were frozen before induction of differentiation (day
0) and 2, 4 and 8 days after the start of the differentiation process.
Oil Red O staining
Oil Red O (0.35% Oil Red O in Isopropanol, Sigma-Aldrich, O-0625) was mixed with dH2O
(v:v 6:4). Adipocytes were fixed with 4% paraformaldehyde and washed three times with PBS
prior to staining. Cells were dried and the Oil Red O solution added for 10 min. Subsequently,
cells were washed four times with dH2O and dried. Pictures were taken with an EVOS XL
Core Cell Imaging System (Thermo Fisher Scientific Inc., Waltham, Massachusetts MA, USA).
Real-time gene expression
RNA was isolated from brain areas, eWAT and primary adipocytes using a commercially avail-
able kit (RNeasy, Qiagen, Hilden, Germany). For qPCR analyses of tissues, equal amounts of
RNA were transcribed to cDNA using Superscript III (Invitrogen, Darmstadt, Germany). For
qPCR analyses of primary adipocytes, 0.5 μg RNA were transcribed to cDNA using the Quanti-
Tect Reverse Transcription kit (Qiagen, Hilden, Germany). Gene expression levels were asses-
sed on a 7600HT TaqMan Fast Real-Time PCR System (Applied Biosystems, Carlsbad, CA,
USA) by using either TaqMan probes (Dusp6: Mm00518185_m1, Hprt: Mm01545399_m1,
Thermo Fischer Scientific, Inc., Rockford, IL USA) and the respective TaqMan mastermixes
(Applied Biosystem, Carlsbad, CA, USA), or by using custom-to-order TaqMan low-density
Arrays (Applied Biosystems, Carlsbad, CA, USA) as previously described [27].
Statistical analyses
Statistical analyses were performed by using GraphPad Prism (GraphPad Software, Inc. La
Jolla, CA, USA). Two groups were compared by two-tailed unpaired Student’s t test, three or
more groups by one- or two-way ANOVA followed by Bonferroni post hoc tests, as indicated.
P values lower than 0.05 were considered statistically significant. Results represent means ±
SEM.
Results
Central Dusp6 expression is not affected by leptin, diet-induced obesity
or prolonged fasting
Dusp6 is highly expressed in the brain of developing as well as adult mice [16]. A comparison
of 30 mouse strains further revealed an association between allelic Dusp6 variant I62M
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(rs13480726) and forebrain weight and structure [18]. Here, we aimed to delineate the distri-
bution of Dusp6 mRNA in selected brain areas of leptin-deficient Lepob mice, and assess the
impact of leptin on Dusp6 expression. We furthermore aimed to assess in C57Bl/6J mice
whether hypothalamic Dusp6 expression is regulated by diet-induced obesity or prolonged
fasting and refeeding.
First, we assessed the impact of leptin on CNS Dusp6 gene expression in adult ad libitum
(ad lib) chow-fed leptin-deficient (Lepob) mice (71.12 ± 0.71g) treated either with human
recombinant leptin (leptin) or vehicle saline (saline ad lib). An additional group of saline-
treated Lepob mice was pair-fed to the lower food consumption of the leptin-treated mice
(saline pf). Six days of subcutaneous treatment with 1 mg/kg leptin significantly decreased
body weight and food intake, as expected (Fig 1A and 1B). Saline pf mice displayed a similar
decrease in body weight. Subsequent qPCR analyses in hypothalami of saline ad lib mice dis-
played similar Dusp6 expression in the hypothalamus, striatum, amygdala, midbrain and hind-
brain (Fig 1C). Moreover, leptin treatment had no effect on Dusp6 expression compared to
Saline ad lib or Saline pf mice (Fig 1C). In adult C57Bl/6J mice exposed to chow-diet or HFD
for 6 months, we found similar hypothalamic Dusp6 levels (Fig 1D).
We next aimed to assess the impact of a chronically negative energy balance on hypotha-
lamic Dusp6 expression levels, and subjected 8-week-old chow-fed C57Bl/6J mice to 12, 24 or
36 h of fasting. Moreover, by applying refeeding with fat free diet (FFD) vs. HFD, we aimed to
delineate the impact of circulating free fatty acids and other lipid species, which are known to
surge after both prolonged fasting and HFD exposure, from the impact of other macronutri-
ents such as protein or carbohydrates. Quantitative PCR analyses neither showed alterations of
Fig 1. Central Dusp6 expression is not affected by changes in body composition or nutrition. Decreased body weight (A) and food intake (B) but
unchanged levels of Dusp6 mRNA in brain areas (C) of chow-fed Lepob mice treated daily for 6 days with 1 mg/kg of leptin (Leptin) and chow-fed Lepob
mice treated with saline but pair-fed (Saline pf) to the Leptin group, compared to ad libitum fed saline controls (Saline ad lib) (n = 5–6 mice; food intake:
n = 3 cages). Dusp6 mRNA levels were also assessed in (D) chow-fed lean vs. HFD-fed C57B/6J mice (n = 6–8), and in (E) chow-fed lean C57Bl/6J
undergoing fasting or refeeding with fat free or high-fat diet (FFD/HFD; n = 6–8). Means ± SEM.
https://doi.org/10.1371/journal.pone.0183488.g001
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hypothalamic Dusp6 mRNA levels by fasting nor by FFD or HFD feeding, which indicates that
both circulating lipids and a chronically negative energy balance have no impact on hypotha-
lamic Dusp6 expression (Fig 1E).
Diet-induced obesity induces Dusp6 mRNA levels in white adipose
tissue
We next examined whether Dusp6 is expressed in vitro in primary adipocytes from inguinal
white adipose tissue (iWAT), and altered during differentiation from pre-adipocytes into adi-
pocytes. Oil Red O staining revealed a profound increase in triglycerides during differentiation
(Fig 2A), but unaltered Dusp6 expression (Fig 2B). In vivo, we assessed whether diet-induced
obesity can alter Dusp6 expression in epididymal white adipose tissue (eWAT). Dusp6 mRNA
levels were absent from eWAT of KO mice, as expected. In mice exposed to HFD for 6 months
we observed a significant increase in Dusp6 expression in eWAT, compared to chow-fed lean
controls (Fig 2C).
Decreased body weight and altered body composition in young
Dusp6-deficient mice
Young (7 weeks old) chow-fed mice with global DUSP6 deficiency of mixed C57BL/6 and 129
background were viable and fertile, but displayed significantly decreased body weight com-
pared to chow-fed wild type mice (Fig 3A). This decrease in weight was largely attributed to
decreased lean mass (Fig 3B), which may suggest early-life weight retardation. Notably, chow-
fed KO mice displayed a shift in body composition towards slightly elevated fat mass (Fig 3C).
Chronic HFD feeding normalizes lean and fat mass in Dusp6 deficient
mice
Differences in body weight and body composition in chow-fed young WT and DUSP6 KO
mice prompted us to assess whether DUSP6 deficiency would impair the ability of mice to
cope with chronic metabolic stress due to an obesogenic dietary environment. Chow-fed
young mice were placed on HFD (58% calories from fat) and monitored for changes in body
weight, lean mass and fat mass.
DUSP6 KO mice placed on HFD gained significantly more body weight (Fig 4A and 4B)
and lean mass (Fig 4C and 4D) compared to HFD-fed WT mice. Both genotypes gained simi-
lar amounts of fat mass during the diet exposure (Fig 4E and 4F). By the end of the 26 weeks of
HFD exposure, however, we could not find any significant differences in body weight, lean
mass or fat mass. Food intake in DUSP6 WT and KO mice was monitored between weeks 3
and 5 of HFD exposure, but was unchanged between genotypes when normalized per animal
or per kg body weight (Fig 4G) Overall, our data suggest that Dusp6 plays a role in early stages
of life and adipose tissue development. Our data further indicate that DUSP6 deficiency does
not alter the susceptibility of adult mice to develop diet-induced obesity.
Altered lipid homeostasis in DUSP6 deficient mice exposed to HFD
Similar propensities for diet-induced obesity in HFD-fed WT and DUSP6 KO mice were
largely reflected by similar epididymal WAT gene expression levels of key enzymes involved in
adipose tissue biology and function. For instance, we observed unchanged expression levels
for the adipokines adiponectin (AdipoQ), angiotensinogen (Atg), leptin (Lep) and resistin
(Retn) (Fig 5A) in WT and DUSP6 KO mice after 26 weeks of HFD-exposure. Similarly, we
did not detect significant differences in the expression of pro-inflammatory genes such as
Metabolic control by DUSP6
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chemokine C-C motif ligand 2 (Ccl2), interleukin 10 (Il10), interleukin 6 (Il6), integrin subunit
alpha X (Itgax), tumor necrosis factor (Tnf), macrophage antigen Cd68 or hypoxia-inducible
factor 1 (Hif1a) between HFD-fed WT and Dusp6 KO mice (Fig 5B). Genes involved in carbo-
hydrate metabolism (Fig 5C; glucokinase regulatory protein (Gckr), pyruvate dehydrogenase
kinase 2 (Pdk2), pyruvate dehydrogenase kinase 4 (Pdk4) solute carrier family 2 member 1 and
4 (Slc2a1, Slc2a4)), adipogenesis (Fig 5D; C/EBP beta CCAAT/enhancer binding protein beta
and delta (Cebpb, Cebpd), delta-like 1 homolog (Dlk1), Egf-like module containing, mucin-like
hormone receptor-like 1 (Emr1), insulin-induced protein 1 (Insig1), peroxisome proliferator-
activated receptor gamma (Pparg), vascular endothelial growth factor (Vegf)), protein metabo-
lism (Fig 5E; autophagy related 4 homolog C (Atg4c), peptidyl-prolyl cis-trans isomerase B
(Ppib)) or lipolysis (Fig 5F; hormone-sensitive lipase (Lipe), lipoprotein lipase (Lpl)) remained
unchanged between genotypes. HFD-fed DUSP6 KO mice displayed increased levels of fatty
acid transport protein 1 (Fig 5G; Slc27a1), but unchanged levels of CD36 antigen (Cd36), fatty
acid binding protein 4 (Fabp4) or fatty acid binding protein 5 (Fabp5), compared to HFD-fed
Fig 2. Diet-induced obesity increases Dusp6 expression in eWAT. Primary pre-adipocytes isolated from inguinal WAT of C57Bl/6J mice undergoing
differentiation to mature adipocytes displayed increased triglyceride content (A; representative images Oil Red O staining), but unchanged Dusp6 mRNA
levels (B; two independent wells from two cell preparations). Dusp6 mRNA was absent in epididymal WAT of HFD-fed DUSP6 KO mice, and increased in
HFD-fed obese compared to chow-fed lean C57Bl/6J mice (C; n = 3–8). Means ± SEM, *p<0.05.
https://doi.org/10.1371/journal.pone.0183488.g002
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WT controls. HFD-fed DUSP6 KO mice further displayed increased low-density lipoprotein
receptor (Ldlr), but other enzymes involved in lipoprotein metabolism (Fig 5H; ATP-binding
cassette transporter (Abca1), apolipoprotein A-V (Apoa5), apolipoprotein E (Apoe), low-den-
sity lipoprotein-related protein 1 (Lrp1) or scavenger receptor class B member 1 (Scarb1))
remained unchanged. The expression of lipogenesis enzymes (Fig 5I; acetyl-CoA carboxylase
alpha (Acaca), carbohydrate-responsive element-binding protein (Chrebp), fatty acid synthase
(Fasn), stearoyl CoA desaturase 1 (Scd1), sterol regulatory element binding protein-1 (Srebpf1))
remained unchanged except for glycerol kinase (Gyk), which was increased in eWAT of
DUSP6 KO mice. Cholesterol metabolism (Fig 5J) appeared to be induced in eWAT of DUSP6
KO mice, as indicated by increased ATP-binding cassette sub-family G member 1 (Abcg1)
expression and a trend for increased 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase
(Hmgcr) levels. Overall, eWAT gene expression levels appears largely inconspicuous, which is
also reflected by unchanged total ERK or phospoho-ERK protein levels (data not shown).
However, a limited number of deregulated genes (Slc27a1, Ldlr, Gyk, Abcg1) points towards
slightly increased cholesterol and lipid metabolism in HFD-fed DUSP6 KO mice.
Impaired glucose homeostasis in DUSP6 deficient mice
DUSP6 was recently associated with gluconeogenic gene expression and hepatic gluconeogen-
esis [17], potentially mediated via direct interaction with and dephosphorylation of FOXO1
[24,25]. We here aimed to delineate the impact of germline DUSP6 ablation on systemic glu-
cose tolerance in young and lean chow-fed DUSP6 WT and KO mice, and subsequently in
WT and KO mice subjected to chronic HFD exposure. Glucose tolerance tests revealed signifi-
cantly increased glucose levels 15 min after a glucose bolus in young chow-fed DUSP6 KO
mice (Fig 6A, left panel). Glucose excursions quickly normalized and area under the curve
(AUC) levels remained unchanged (Fig 6A, right panel). DUSP6 KO mice subjected to HFD
for 16 weeks revealed the same glucose intolerance as chow-fed KO mice, i.e. unchanged base-
line glucose levels, significantly increased glucose excursions 15 min after a glucose bolus, and
a quick normalization of glucose levels with unchanged AUC levels (Fig 6B). Overall, these
data suggest that DUSP6 deficiency impairs glucose tolerance independently of diet exposure
and body weight or lean mass changes.
Fig 3. Body weight and body composition in chow-fed DUSP6 WT and KO mice. Age-matched DUSP6 WT and KO mice (Age 7.3 ± 0.3 vs.
7.6 ± 0.1 weeks) were fed standard chow-diet and monitored for their body weight (A), lean mass (B) and fat mass (C). n = 8. Means ± SEM, **p<0.01.
https://doi.org/10.1371/journal.pone.0183488.g003
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Fig 4. Body weight and body composition in HFD-fed DUSP6 WT and KO mice. DUSP6 WT and KO
mice were exposed to high fat diet (HFD; D12331; 58% kcal fat; Research Diets Inc., New Brunswick, USA)
for 25 weeks, and evaluated for changes in body weight (A,B), lean mass (C,D) and fat mass (E,F). Food
intake per animal or kg body weight was monitored between weeks 3 and 5 (G). A-F: n = 8–9; G: n = 3–5
(group housed mice). Means ± SEM, ***p<0.001, ****p<0.0001.
https://doi.org/10.1371/journal.pone.0183488.g004
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Discussion
Here, we report effects of global genetic ablation of ERK-specific dual specificity phosphatase 6
on systemic energy and glucose homeostasis in mice. Our data reveals slightly increased fat
mass, but reduced body weight and lean mass in young, chow-fed DUSP6 KO mice, reminis-
cent of early-age weight retardation. Exposure to HFD leads to a compensation of body com-
position in both genotypes and increased expression of genes involved in lipid and cholesterol
metabolism in eWAT of DUSP6 KO mice, compared to WT controls. Regardless of body
Fig 5. Gene profiling of epididymal white adipose tissue. Low-density microarrays for adipokines (A) and enzymes important for inflammatory
processes (B), carbohydrate metabolism (C), adipogenesis (D), protein metabolism (E), lipolysis (F), fatty acid transport (G), lipoprotein metabolism (H),
lipogenesis (I) and cholesterol metabolism (J) revealed a significant up-regulation of genes important for fatty acid transport (Slc7a1), lipogenesis (Gyk),
lipoprotein metabolism (Ldlr), and steroid metabolism (Abcg1) in eWAT of HFD-fed Dusp6 KO mice, compared to WT controls. All results were normalized
to the expression of 18S. Means ± SEM, n = 8. *p<0.05, **p<0.01.
https://doi.org/10.1371/journal.pone.0183488.g005
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weight or body adiposity, glucose tolerance was perturbed in both chow-fed lean or HFD-fed
obese DUSP6 KO, compared to their respective WT controls.
DUSP6 is undetectable in skeletal muscle and testis, but widely expressed in tissues such as
lung, heart, spleen, thymus, kidney, liver, WAT and brain [19,23,28]. In the brain, Dusp6
seems to act as neuro-protectant in cells exposed to oxidative stress: primary cortical neurons
with Dusp6 overexpression blocked the nuclear translocation of ERK1, leading to protection
from glutamate-induced oxidative toxicity [29]. A similar protective role for Dusp6 was found
in non-neuronal oligodendrocytes in the CNS, where Dusp6 mRNA expression was increased
after glutamate treatment [30]. In contrast, LPS treatment led to a reduction of Dusp6 mRNA
levels in microglia [31]. We found unaltered Dusp6 mRNA levels in various brain areas of
Fig 6. DUSP6 ablation impairs glucose tolerance. Intraperitoneal bolus injections of 2 g glucose per kg body weight led to a temporary increase in
glucose excursions 15 min after injection but unchanged area under the curve levels in (A) chow-fed (n = 9–10) and (B) 16-weeks HFD-fed DUSP6 WT
and KO mice (n = 9). Means ± SEM; *p<0.05.
https://doi.org/10.1371/journal.pone.0183488.g006
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mice subjected to substantial metabolic challenges such as leptin injections, diet–induced obe-
sity or prolonged fasting and refeeding. Accordingly, DUSP6, at least at the level of gene
expression, does not seem to be a crucial negative feedback regulator to dampen the extent
and duration of ERK signaling in response to metabolic stimuli in the selected brain areas
associated with metabolic homeostasis.
Elevated fat mass in young DUSP6 KO mice points towards slightly augmented adipogen-
esis, potentially due to increased basal ERK activity [19] in eWAT. Notably, we were unable to
find such increased ERK activation in eWAT of DUSP6 KO mice exposed to HFD for 25
weeks compared to HFD-fed WT controls. Whether deregulated ERK activity acts as driving
force for earlier effects of DUSP6 deficiency on body weight gain after 9 or 16 weeks of HFD
exposure remains to be tested. Overall, the long HFD exposure may facilitate compensatory
mechanisms that help overcoming DUSP6 deficiency and ERK hyperactivation, e.g. via alter-
native phosphatases, kinases or scaffold proteins, which would explain similar body weights
and body composition in WT and KO mice at the end of the monitoring period.
Unaltered Dusp6 expression in primary preadipocytes undergoing differentiation to mature
adipocytes does not support a major role of DUSP6 in adipogenesis. Rather, DUSP6 may play
a role in controlling metabolism in mature adipocytes, which is in line with our finding of
upregulated Dusp6 mRNA levels in eWAT of DIO mice. Indeed, gene profiling studies in
white adipose tissue show an induction of anabolic, mostly lipogenic genes in HFD-fed
DUSP6 KO mice. Amongst the genes increased in eWAT of DUSP6 KO mice, we found glyc-
erol kinase (Gyk), which is absent from adipocytes under normal conditions [32]. Induction of
Gyk expression and activity, for instance via aquaporin 7 (Agp7) deficiency or peroxisome pro-
liferator-activated receptor γ (PPARγ) activation, results in the re-utilization of glycerol as
direct source of glycerol-3-phosphatse to facilitate re-esterification of free fatty acids and a pro-
gressive accumulation of triacylglycerol towards adipocyte hypertrophy [32]. This is in line
with the upregulation of low-density lipoprotein receptor (Ldlr) in eWAT of HFD-fed DUSP6
KO that points towards increased low-density lipoprotein uptake with elevated cholesterol,
free fatty acid and lipid transport into the adipocytes. LDLR KO mice were resistant to devel-
oping diet-induced obesity when exposed to a Western diet (WD) [33,34]. However, a conflict-
ing report suggests that LDLR KO mice are prone to high body adiposity when fed with a
diabetogenic diet rich in fat and sugar [35]. Accordingly, the role of LDLR in the etiology of
body adiposity remains unclear. Our hypothesis of altered lipid homeostasis in eWAT of
DUSP6 KO mice is further supported by increased expression of ATP-binding cassette sub-
family member 1 (Abcg1) that has been linked with increased cholesterol and phospholipid
transport into macrophages [36]. ABCG1 was further shown to promote triglyceride storage
and fat mass growth in mice, and virally mediated Abcg1 knockdown in adipose tissue dimin-
ished adiposity and weight gain in HFD-fed mice [37]. Elevated levels of ABCG1 in eWAT of
DUSP6 KOs are thus indicative of increased lipid and cholesterol flux and adiposity.
Last, we found elevated levels of solute carrier 27 a1 (Slc27a1), the most abundant fatty acid
transporter in adipocytes, in eWAT of HFD-fed DUSP6 KO mice. SLC27A1 translocates to
the plasma membrane upon insulin stimulation, where it mediates long-chain fatty acid uptake
to facilitate triglyceride synthesis and lipid storage [38]. However, SLC27A1 does not appear to
drive adiposity based on the similar body adiposities found in HFD-fed SLC27A1 WT and KO
mice [39]. Nonetheless, since Slc27a1 ablation was linked with higher insulin sensitivity [39],
elevated Slc27a1 expression in our HFD-fed DUSP6 KO mice suggest impaired eWAT insulin
sensitivity. Indeed, we observed impairment of glucose tolerance in HFD-fed DUSP6 KO
mice, but the role of eWAT in that process remains unclear. Overall, augmented lipid metabo-
lism and an anabolic eWAT state may explain why DUSP6 KO mice displayed normalization
of weight retardation after exposure to an obesogenic environment. However, more profound
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changes in the expression of anabolic genes may have occurred before our measurements in
HFD exposure weeks 9 to 16, where KO mice show a significantly larger weight gain compared
to WT mice to compensate for the early weight retardation.
In a previous report, DUSP6 KO mice exposed to HFD displayed decreased fat mass gain
and lower propensity for diet-induced obesity [23]. A subsequent report corroborated the
resistance to diet-induced-obesity in DUSP6 KO mice and attributed this to an alteration of
the gut microbiome, which conferred obesity protection by ameliorating the gut microbiota
response to diet-mediated stress [40]. Accordingly, fecal transplants of microbiota from
DUSP6 KO mice significantly increased energy expenditure and reduced weight gain in recipi-
ent germ-free wild-type mice exposed to HFD [40]. Our data stand in contrast to these earlier
studies, displaying similar propensities for diet-induced obesity, as evidenced by similar fat
mass, lean mass and body weight in DUSP6 WT and KO mice after 26 weeks of HFD expo-
sure. Reasons for this discrepancy remain elusive. Importantly, our study and the studies by
Feng [23], Ruan [41] and colleagues were performed using mice with the same genetic muta-
tion [19]. However, our mice had a mixed genetic background (C57Bl/6J and 129) compared
to the pure C57Bl/6J background of mice used by Feng [23], Ruan [41] and colleagues (Jackson
Lab strain #025564).
Both mice with a pure 129 or C57Bl/6J background were shown to be equally susceptible to
DIO [41]. Others report full [42] or partial [43] protection from DIO in 129 mice compared to
C57Bl/6J mice. Accordingly, a differential effect of a mixed vs. pure background on the meta-
bolic phenotype of DUSP6 KO mice cannot be ruled out completely. Our data reveals a con-
siderable propensity for DIO in HFD-fed WT and DUSP6 KO mice on a mixed background.
Alterations in housing conditions, diets or the gut microbiological environments are known to
serve as confounding factors for phenotypic disease differences [44]. For instance, differences
between labs in the propensity of genetically identical Toll-like receptor KO mice to develop
obesity and comorbid sequelae may be attributed to divergence of the gut microbiota after pro-
longed breeding in the respective housing facilities [45,46]. Our data suggests that discrepan-
cies between reports on metabolic dysfunction in DUSP6 KO mice may underlie a similar
principle. In that respect, especially the difference in the genetic background appears of major
importance. Reports showed that even subtle differences in background in C57Bl/6J vs. C57Bl/
6N mice can have a differential effect on obesity susceptibility, likely driven by changes in the
microbiome composition [47]. Other reports highlight the genetic background as important
denominator for the microbiome composition [48–50], which can have a profound impact on
cardiovascular and metabolic phenotypes [42,51]. Overall, however, environmental influences
appear to have a greater impact on the microbiome compared to the genetic background [49].
In fact, only 19% of the variance in murine gut microbiota composition appears to be driven
by background genetics, while 31.7% are driven by the relative contribution of cage effects and
45.5% by inter-individual variations inherent to a mixed co-housing design [52].
The standardization of microbiota compositions in DUSP6 WT and KO mice between labs
and mouse husbandry rooms would be the ideal solution to solve the discrepant findings.
However, at current this approach does not appear feasible. Mouse husbandry facilities often
implement complex barrier rules, and the colonization with a general microbiome composi-
tion will likely only be temporary until the microbiota prevalent at the respective facilities
cause a drift or replacement.
Distinct gut microbiota may also explain discrepant effects of DUSP6 deletion on glucose
tolerance in our study and previous reports. DUSP6 KO mice in our study developed mild
glucose intolerance on chow and high fat diet. Glucoregulatory organs impaired by DUSP6
deficiency remain to be determined, but our data indicates that the effect of DUSP6 is inde-
pendent from body weight or body composition. These data stand in contrast to reports in
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HFD-fed DUSP6 KO mice [23,40] or HFD-fed mice with an antisense oligonucleotide-driven
knockdown of hepatic DUSP6 [53], which revealed improved glucose homeostasis concomi-
tant with a protection from obesity after DUSP6 inactivation. Reasons for this discrepancy
remain elusive, but may entail differential macronutrient contents in the HFDs used between
reports; we used a ‘Surwit diet’ high in fat and sucrose with vegetable (coconut) oil as main
source of dietary fat (58% calories from fat), while the two previous studies [23,40] used HFDs
with animal fat, i.e. lard, as source of dietary fat (45% or 60% calories from fat, respectively).
Mice display a comparable reduction in microbial diversity and a shift from commensal gut
microbiota towards a pro-obesogenic profile, indicated by a shift in the ratio of firmicutes to
baceteroidetes, when exposed to HFD or WD (reviewed in [54]). Germ-free mice were pro-
tected from diet-induced obesity when exposed to WD which was based on high sucrose con-
tent and beef tallow as fat source [55,56]. However, when exposed to HFD with lower sucrose
content and coconut oil as source for dietary fat, germ-free mice displayed a normal propen-
sity to develop DIO compared to conventionally housed HFD-fed mice [56]. Accordingly,
despite similar macronutrient content, sucrose levels and the type and source of fat in WD vs.
HFD seem to determine whether alterations in the host microbiome interaction are causally
linked with the development and maintenance of DIO. Accordingly, the type of HFD and
potentially distinct housing conditions with differential microbiota prevalent in the animal
facilities may help to explain discrepant findings between our study and previous reports in
genetically identical DUSP6 KO mice.
Last, our finding of early-age weight retardation, i.e. reduced body weight and lean mass, in
young DUSP6 deficient mice corroborates an earlier report showing decreased body weight in
young DUSP6 KO mice [23]. Exact molecular underpinnings for the early-age weight retarda-
tion in response to DUSP6 deficiency remain unknown, but may include hyperactivation of
ERK [19] at multiple growth-regulating organs, for instance at the level of the hypothalamus
and pituitary. Future studies should moreover clarify the role of DUSP6 in pre- and postnatal
development and in the control of lean mass and body length via the growth hormone axis.
In summary, we corroborate an earlier report showing reduced weight and lean mass in
young DUSP6 KO mice. Mechanisms and sites-of-action for this early weight retardation phe-
notype remain elusive. We further show that DUSP6 deficiency has limited effects on the regu-
lation of systemic energy homeostasis, but impairs glucose homeostasis in adult mice; these
data stand in contrast to earlier reports which suggest protection from DIO and glucose intol-
erance in the absence of DUSP6, potentially mediated via alterations in the gut microbiome
[23,40,53]. Importantly, all studies were conducted in mice with the same genetic mutation,
but with a different genetic background of pure C57Bl/6J vs. mixed 129 x C57Bl/6J, and differ-
ent types of HFD. Future studies should clarify this potential role of the genetic background, of
the diet, and of host microbiome interactions for DUSP6-ERK signaling and the susceptibility
for DIO and etiology of metabolic disease.
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